The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition.
Learn more orphan products.
Atovaquone(Brand name: Mepron®) - Manufactured by Glaxo Wellcome Inc. FDA-approved indication: For the acute oral treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in patients who are intolerant to trimethoprim-sulfamethoxazole. Prevention of PCP in patients who are intolerant to trimethoprim-sulfamethoxazole. National Library of Medicine Drug Information Portal